Suggested Timeline from WP1 ,,RMOA" content plan - PFAS RESTRICTION Milestones Preparation of Call for Evidence (including questionnaire and information document) in agreement between MS 2nd version questionnaire Draft of information document (DE/NL CA) Commenting round (all MS) Revision and draft of 3rd version of questionnaire and information document for WebEx (DE/NL CA) Detailed discussion of questionnaire and information document (all MS) Final version (DE/ NL CA) Notification into PACT (DE/ NL CA) Call for Evidence (all MS and ECHA with news alerts and websites of all MS with Link to Helpdesk webpage) Preparation of Restriction option analysis document (all MS) Discussion of responses received so far, data (all MS) Decision on meetings with industry (all MS) Discussion of restriction scope and options (all MS) Decision on which restriction options should be presented and discussed in RiME+ (all MS) Meetings with stakeholders and industry RIME+ Dortmund 1st draft of restriction option analysis document (all MS) Contributions of first drafts of document parts according to lead in work packages and sub-work packages (all MS) Merge of contributions, redrafting (DE/ NL CA) 2nd draft of restriction option analysis document (all MS) Redrafting by all MS From Till 30 April 2020 till 30 March 2020 31 March 2020 15 April 2020 17 April 2020 WebEx 20 April 2020 24 April 2020 27 April 2020 04 May 2020 30 July 2020 May 2020 Mid-November 2020 WebEx 24 August WebEx 28 September August/September 2020 20/21 October 2020 02 October 2020 24 September 2020 25 September 2020 05 October 02 October 2020 23 October 2020 16 October 2020 Merge of contributions, redrafting (DE/ NL CA) Finalisation of document, i.e. clarification of restriction options and scope (all MS) Last redrafting by all MS Finalisation (DE/ NL CA) Restriction option analysis document to be uploaded on CIRCA (DE/ NL CA) Commenting (by all other MS not part of group) Consideration of comments/if needed redrafting of document (DE/ NL CA in agreement with group) RMOA-Conclusion, PACT-Update 19 October 2020 23 October 2020 20 November 2020 26 October 2020 10 November 2020 09 November 2020 20 November 2020 23 - 27 November 2020 01 December2020 01 January 2021 04 January 2021 28 January 2021 29 January 2021

Wows rome JERUCTUAL KORIULAL sryte Rs GROANISNS GP, CBC32a,F,lP7,oC0sO0eO0yHR nttooxsicity mice DOSE OR CONCEMTRATION: en ~NAArH,IEE!

I. i Ask the experts why more Ld FY ore | aN RN LTii i than anyother foam

- arcana avn THOSE san BoY0 DUPONT GERRY KENNEDY PONT AUG or BLBw HkoChmn aRedn BBieyY 3 i RON RIm CffARDSe ON n DUPOxIi~t aIns, a F~n~ R.

`DuPont DuPont HMHaeasesktkeielnlllg LLMaaibbnouortraaetstoorryy Visit Visit MJeuentien3g0M,2in00u0tes June 30, 2000 IInn AAtttteennddaannccee DDJouuhpPnooOnn'ttC:onnor, Reproductive and Developmental Toricology JJJBoooohhhbnnnHGOGoaka'Cnnenon,onoEnnnc,o,otrEE,onnxRvviieicrrpooorlnnoommdgeuyencntttiaavlleFFaaanttede: Developmental Toxicology .

-WE MiGGMleeilololeerrUtgg/DgeeYYHH--.D.Dyynneeoonn//33MMI/UUSS ER So5S/P3oR/I2o0o|l l1O0=Os5PPMM Gunther TToo JJiimm EE..

Protocol Amendment:CancerIncidence in 3M Workers Protocol Amendment: Cancer Incidence in 3M Workers TTCohhteetcacugurerrrGeernnottlvlyyeffauunnndddeeSddasisntttuuPddayyuwlwiliPllllaeenvvtaafllauucaaittleeitcceaasnnwccieetrrhiinsnpcceiicddieefnniccceereiinfne33rMMencwweoortrkokeeerxrsspoaasttuttrhheee to aCafmrmoomm,maogotnnehieiGuuMmrmionvppneeeerrasffnolludtuoaoSrroaaoinoondcctttPWaainansuoocalaottPenelsa((inAAntPPfFcFaOaOc)ni],cl.ietTTirehhsreeewgcciaaistnnthcrcieseeprrse.iicnnPiccfriiiecddveerinenoccfueeesrdderanaettcsaaeeawwtrioilclllhexbbiepedoeaonsbbtuiitrnafeiiinentdoeedda pfperoolottmdeennhtttiihiagaelhlMaaAssPissnFoonccOeiisaaeottxiitopaoonnaswwnuidritteW hhJttiohshbceesorrcniiossskimknopofacfarddneyycdiienntrggorffetrrghoooimsmsterppiwrerooshs.sottPaahrtteeeevlccdioaaounnnsccleeryrrelsiionenwawwroecorxhrkpkieodersresesndtwwijfhhoioeobds.aA hlienldgehriigngh qAuPeFsOtieonxpwoassurtehejoqbusalciotmy opfatrheed etoxptohsousreewmhoodehle,ldinoandldyiltoiwonetxoptohseed jobs.

Douglas.

wr a IInntteerrnnaall CCoorrrreessppoonnddeennccee cccc:: RR..

FFIINNAALL AAMMMMOONNIIUUMM PPEERRFFLLUUOORROOOOCCTTAANNOOAATTEE ((CC88)) AASSSSEESSSSMMEENNTT OOFF TTOOXXIICCIITTYY TTEEAAMM ((CCAATTTT))RREEPPOORRTT J b/ N / AAuugguusstt 22000022 DEP | 2614 DDeeppaarrttmmeenntt ooff EEnnvviirroonnmmeennttaall PPrrootteeccttiioonn -- pprroommoottiinngg aa hheeaalltthhyy eennvviirroonnmmeenntt 22661144..00000011 EEXXEECCUUTTIIVVEE SSUUMMMMAARRYY EnvironPPmuuerrnsstuuaaalnnttPrt1oo0taaeccctooinnosnseeannnttdoorHrddeeearrltsshiiggannneeddd HNNuoomvveaemmnbbReeerrso11u44,r, c22e00s0011debbpeaerttwtwmeeeeennntstth,heeanWWdeessEtt.

AALLGGIICCIIDDAALL AACCTTIIVVIITTYY I TESTE SUBSS TANCT E SUBSTA0N 00G 00E 0 IIddeennttiittyy:: AArefmmeirixxrtteuudrreetoccaoonsnttPaaiFinnOiinSngg, ppFeeCrr-ff9ilu5uo,orrooorooccattsaannaeescsuuolffmfoopnnaoattnee,e, wwnohthfiiccFhhC-mm2a0a3yy.aalls(s1oo- bbee rOecftearnreedsutlofoansicPaFcOidS), (FCCA-S95#, o27r9a5s-3a8-c3o)m. ponent of FC-203. (1- Octanesulfonic acid) (CAS # 2795-39-3).

] Be oT cia lr i aie : -- i : ---- = a 3 CARTE 3 TA - igaRe -- MMiissssiissipppii RRiiver Pooooll 2 IInntteensive Sttuuddy ooff PPeerrfflluuoorroocchheemmiiccaallss iinn FFiisshh aanndd WWaatteerr:: 200099 8 March 2010 ES, Minnesota Pollution Control Agency - 281177..000011 Exhibit 2817 State of Minnesota v. 3M Co., Court File No. 27-CV-10-28862 MMiinnnnee5ss2oo0ttaaLaPPfooallylleuutttitiooennRCCoooanndttrrNooollrtAAhggeennccyy SS5aa2ii0nnttLPaPafauaulyl,,etMMtNeN R55o551a15d555N--44o11rt99h44 hhittttpp::////wwewnww..ppecaa.ssttaattee..mmnn..uuss 665511--229966--66330000 oorr 880000--665577--33886644 ttoollll ffrreeee.

mm~ DEPARTMENT 1 OF HEALTH 0 E HCCE LL EE N AA NN B frW L AaANTiEs&R E LMEEGNOANECNYT BBaacckkggrroouunndd DDooccuummeenntt TTooxxiiccookkiinneettiicc MMooddeell ffoorr PPeerrfflluuoorrooooccttaannee SSuullffoonnaattee ((PPFFOOSS)) aanndd PPeerrfflluuoorrooooccttaannooiicc AAcciidd ((PPFFOOAA)) aanndd IIttss UUssee iinn tthhee DDeerriivvaattiioonn ooff HHuummaann HHeeaalltthh--BBaasseedd W Waatteerr GGuuiiddaannccee VVaalluueess MMaayy 22001177 NOTE:Thefollowing model was developed by the Minnesota DepartmentofHealth (DH).

PFHxA Restriction Proposal Filtration and Separation Coalition Discussion with the Belgian Committee REACH 15 June 2021 1 AGENDA Discussion on the PFHxA Restriction Proposal 1 The Filtration and Separation Coalition 2 Filtration Value Chain 3 Key Properties of C6 4 Applications 5 Emissions 6 Alternatives to C6 7 Socio-economic implications 8 Conclusion 2 THE FILTRATION AND SEPARATION COALITION The coalition includes the three leading manufacturers of filtration and separation media, with a strong presence within the European Union, including France, Finland, Germany, Italy, and the United Kingdom. 3 !

(SPF Sant Publique - FOD Volksgezondheid) From: Sent: To: envcoord.health.fgov.be on behalf of (SPF Sant Publique - FOD Volksgezondheid) < .